Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial
暂无分享,去创建一个
C. Cluver | S. Walker | R. Hiscock | S. Tong | D. Hall | E. Decloedt | T. Kaitu'u-Lino | F. Brownfoot | S. Schell | B. Mol
[1] C. Cluver,et al. Pravastatin, proton pump inhibitors, metformin, micronutrients and biologics: new horizons for the prevention or treatment of preeclampsia. , 2020, American journal of obstetrics and gynecology.
[2] R. Ehrenkranz,et al. Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1). , 2020, American journal of obstetrics and gynecology.
[3] Fuchuan Wang,et al. Effect of Metformin on a Preeclampsia-Like Mouse Model Induced by High-Fat Diet , 2019, BioMed research international.
[4] Jilin Hu,et al. Protective effect of metformin on a rat model of lipopolysaccharide‐induced preeclampsia , 2019, Fundamental & clinical pharmacology.
[5] J. Louw,et al. Pharmacokinetic Interaction of Green Rooibos Extract With Atorvastatin and Metformin in Rats , 2019, Front. Pharmacol..
[6] Yu Han,et al. Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[7] B. Mol,et al. A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial): study protocol , 2019, BMJ Open.
[8] T. Stürmer,et al. Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes , 2019, JAMA pediatrics.
[9] A. Khalil,et al. Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta‐analysis of randomized trials , 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[10] P. Schubert,et al. Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial , 2018, American journal of obstetrics and gynecology.
[11] M. Loeken,et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. , 2018, American journal of obstetrics and gynecology.
[12] L. Magee,et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. , 2018, Hypertension.
[13] Ø. Salvesen,et al. Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs , 2018, The Journal of clinical endocrinology and metabolism.
[14] T. Lyons,et al. Risk of pre‐eclampsia in women taking metformin: a systematic review and meta‐analysis , 2018, Diabetic medicine : a journal of the British Diabetic Association.
[15] J. Gardosi,et al. Customized growth charts: rationale, validation and clinical benefits. , 2018, American journal of obstetrics and gynecology.
[16] José Guilherme Cecatti,et al. Correction: The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight , 2017, PLoS medicine.
[17] José Guilherme Cecatti,et al. The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight , 2017, PLoS medicine.
[18] Luis F. Goncalves,et al. Perinatal and Hemodynamic Evaluation of Sildenafil Citrate for Preeclampsia Treatment: A Randomized Controlled Trial , 2016, Obstetrics and gynecology.
[19] L. Parry,et al. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction. , 2016, American journal of obstetrics and gynecology.
[20] K. Joseph,et al. Maternal Morbidity Associated With Early-Onset and Late-Onset Preeclampsia , 2014, Obstetrics and gynecology.
[21] K. Joseph,et al. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. , 2013, American journal of obstetrics and gynecology.
[22] D. Chou,et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[23] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[24] D. Grové,et al. Expectant management of early onset, severe pre‐eclampsia: maternal outcome , 2000, BJOG : an international journal of obstetrics and gynaecology.
[25] D. Hall. Understanding expectant management of pre-eclampsia : review , 2016 .
[26] P. Marathe,et al. Steady-State Pharmacokinetics of a Novel Extended-Release Metformin Formulation , 2005, Clinical pharmacokinetics.
[27] Asif Ahmed,et al. Induction of Placental Heme Oxygenase-1 Is Protective Against TNFα-induced Cytotoxicity and Promotes Vessel Relaxation , 2000, Molecular medicine.